ADAP
Adaptimmune Therapeutics
ADAP
ADAP
78 hedge funds and large institutions have $116M invested in Adaptimmune Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 17 closing their positions.
Holders
78
Holders Change
-10
Holders Change %
-11.36%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
16
Reduced
24
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–